Frontlight ResearchEarly access
Trial site
Fondazione del Piemonte per l'Oncologia (IRCCS)
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer2 trials
- Triple-negative breast cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Jazz Pharmaceuticals2 trials
- Hoffmann-La Roche1 trial
- Istituto Oncologico Veneto IRCCS1 trial
- Pfizer1 trial
- PMV Pharmaceuticals, Inc1 trial
Running trials
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026